Discovery channel feed

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

5 months ago
R&D
In Focus

Stud­ies show how once-ob­scure DNA cir­cles dri­ve can­cer, and maybe even how to stop them

6 months ago

At­las of tu­mors re­veals in 3D how cells change in­to can­cer

6 months ago
R&D
Diagnostics

Jim Wil­son se­cures $100M for glob­al ap­proach aimed at re­viv­ing gene ther­a­py field

7 months ago
Deals
Manufacturing

Lasker Award goes to three sci­en­tists who pi­o­neered re­search be­hind GLP-1 drugs

7 months ago
People

A teenag­er faced con­stant seizures. Could a drug de­vel­oped just for him stop them?

10 months ago
R&D
In Focus

To tack­le a dead­ly brain dis­ease, sci­en­tists de­vise small but charm­ing epi­ge­net­ic edit­ing tool

10 months ago
R&D

Law­mak­ers con­sid­er lim­it­ing how long ex­ist­ing WuXi con­tracts can con­tin­ue

Last year
Deals
China

David Bak­er's lab re­leas­es new pro­tein de­sign and study tools as AI race ac­cel­er­ates

Last year
R&D
AI

Once a sci­en­tif­ic back­wa­ter, pro­tein re­search at­tracts bil­lion-dol­lar deals and high-pro­file pub­li­ca­tions

Last year
In Focus
Diagnostics

New David Liu study de­tails virus-like de­liv­ery sys­tem for prime edit­ing

Last year
Cell/Gene Tx

Feng Zhang's lat­est gene edit­ing trawl reels in 188 new CRISPR sys­tems

Last year
R&D
Cell/Gene Tx

Ful­ly syn­thet­ic genome nears com­ple­tion in a step to­ward un­rav­el­ing ge­net­ic mys­ter­ies

Last year
R&D
In Focus

How aca­d­e­m­ic cen­ters are try­ing to keep their promis­ing drug dis­cov­er­ies out of the ‘val­ley of death’

Last year
In Focus

Charles Riv­er Lab­o­ra­to­ries to lay off 55 em­ploy­ees in Cal­i­for­nia

Last year
People
Manufacturing

A broad new idea for treat­ing vi­ral in­fec­tions: blow­ing up their pro­tec­tive mem­branes

Last year
R&D

No­var­tis-led group de­vel­ops new class of an­tipar­a­sitic drug tar­get­ing dis­eases caused by try­panosomes

Last year
R&D

Meet ‘Fan­zor,’ a cousin of CRISPR and Feng Zhang’s new gene edit­ing tool

Last year
R&D

Ex­clu­sive: The se­cret to de­sign­ing pro­tein drugs with AI? Gen­er­ate be­lieves it's cryo-EM at un­prece­dent­ed scale

Last year
R&D
AI

FDA is­sues draft guid­ance for clin­i­cal re­search in­to psy­che­delics

Last year
Pharma
FDA+

Deer­field taps NYU Lan­gone Health as lat­est aca­d­e­m­ic part­ner, ink­ing $130M trans­la­tion­al re­search pact

Last year
Deals

Ab­Cellera and Cana­da to in­vest $500M+ to boost an­ti­body man­u­fac­tur­ing and re­search

Last year
Financing
Manufacturing

AI and ma­chine learn­ing: FDA spells out specifics from drug dis­cov­ery to man­u­fac­tur­ing

3 years ago
FDA+

Roche dou­bles down on organoids, hu­man mod­el sys­tems with new re­search in­sti­tute

3 years ago
R&D
Pharma
1234 Next page Last page
A service from the Financial Times
OSZAR »